Literature DB >> 30005334

Personality and prescription drug use/misuse among first year undergraduates.

A Chinneck1, K Thompson2, I T Mahu3, P Davis-MacNevin4, K Dobson5, S H Stewart6.   

Abstract

Emerging adults (18-25 year olds) endorse the highest rates of prescription drug misuse. Attending college or university may confer additional risk. Previous research suggests that personality is an important predictor of many addictive behaviours. Four traits have been consistently implicated: anxiety sensitivity, hopelessness, sensation seeking, and impulsivity. Published studies on personality as a predictor of prescription drug abuse are limited, however, by a primary focus on overall prescription drug use, inconsistent operationalisation of misuse, and failure to control for alcohol use. Sample sizes have been small and non-specific. We sought to better understand how personality predicted the overall use, the medically-sanctioned use, and the misuse of prescription sedatives/tranquilizers, opioids, and stimulants. A large (N = 1755) sample of first year Canadian undergraduate students (mean age = 18.6 years; 68.9% female) was used. We predicted that: anxiety sensitivity would be related to sedatives/tranquilizers, hopelessness to opioids, sensation seeking to stimulants, and impulsivity to all three. Save for the impulsivity to opioid use path, predictions were fully supported in our "any use" model. For medically-sanctioned use: anxiety sensitivity predicted sedative/tranquilizers, hopelessness predicted opioids, and impulsivity predicted stimulants. For misuse: anxiety sensitivity (marginally) predicted sedatives/tranquilizers, sensation seeking predicted stimulants, and impulsivity predicted all three. Our models support using personality-matched interventions. Specifically, results suggest targeting anxiety sensitivity for sedative/tranquilizer misuse, sensation seeking for stimulant misuse, and impulsivity for unconstrained prescription drug misuse. Interventions with early coping skills that pertain to all four traits might be useful for preventing prescription drug uptake and later misuse.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Medically-sanctioned prescription drug use; Personality vulnerability; Prescription drug misuse; Prescription drug use; Undergraduate students

Year:  2018        PMID: 30005334     DOI: 10.1016/j.addbeh.2018.07.001

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  6 in total

1.  A Dangerous "Cocktail": The COVID-19 Pandemic and the Youth Opioid Crisis in North America: A Response to Vigo et al. (2020).

Authors:  Ranmalie Jayasinha; Stephanie Nairn; Patricia Conrod
Journal:  Can J Psychiatry       Date:  2020-07-23       Impact factor: 4.356

2.  Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status.

Authors:  Ty S Schepis; Shawn Acheson; Daniel Zapp; H Scott Swartzwelder
Journal:  Addict Behav       Date:  2019-06-18       Impact factor: 3.913

3.  Big Five personality traits and illicit drug use: Specificity in trait-drug associations.

Authors:  Genevieve F Dash; Nicholas G Martin; Wendy S Slutske
Journal:  Psychol Addict Behav       Date:  2021-11-11

4.  Prescription Stimulant Misuse and Risk Correlates among Racially-Diverse Urban Adolescents.

Authors:  Patricia A Goodhines; Lea E Taylor; Michelle J Zaso; Kevin M Antshel; Aesoon Park
Journal:  Subst Use Misuse       Date:  2020-08-04       Impact factor: 2.164

5.  Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways.

Authors:  Sherry H Stewart; Annie Chinneck; Kara Thompson; Mohammad H Afzali; Raquel Nogueira-Arjona; Ioan T Mahu; Patricia J Conrod
Journal:  Front Psychiatry       Date:  2021-04-27       Impact factor: 4.157

Review 6.  Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings.

Authors:  Lynn M Oswald; Kelly E Dunn; David A Seminowicz; Carla L Storr
Journal:  J Pers Med       Date:  2021-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.